Örmeci Necati, Asiller Özgür Ömer, Parmaksız Ayhan, Kalkan Çağdaş, Üstüner Evren, Altınel Ahmet, Erdem Hakan
Department of Internal Medicine, İstanbul Health and Technology University, İstanbul, Turkey.
Department of Anesthesiology and Reanimation, Ankara University Faculty of Medicine, Ankara, Turkey.
Turk J Gastroenterol. 2024 Jan 26;35(5):398-407. doi: 10.5152/tjg.2024.23286.
BACKGROUND/AIMS:: The percutaneous route is accepted as the most convenient course in the management of hydatid cysts (HCs). The aim of this study is to analyze the efficacy of the Örmeci technique used in the treatment of hydatid cysts.
: This is a retrospective cohort study. Patients with HCs who presented to the Ankara University Faculty of Medicine, Department of Gastroenterology since 1991 were included. Patients with World Health Organization cystic echinococcosis (WHO-CE) types 1, 2, 3A-3B live cysts who were treated percutaneously at least once and followed up after a minimum of 6 months were analyzed.
: A total of 1556 cystic lesions in 1035 patients have been presented to our department since 1991. Five hundred forty-four live HCs in 479 patients were treated with the Örmeci technique. The mean follow-up time was 59.29 months for females and 57.18 for males. The overall clinical success rate of all treated cysts with the Örmeci technique was 94.5%. After the treatment, a statistically significant decrease was found in all WHO-CE cyst types in terms of cyst sizes ( < .001 for all). Mortality, abscess and fistula formation, sclerosing cholangitis, and drug toxicities were not detected. Only 2 patients experienced reversible anaphylaxis during the treatment among 544 cysts (0.36%).
: Hydatid cysts can be treated percutaneously by the Örmeci technique with a high success rate for WHO-CE type 1, 2, and 3B. The Örmeci technique is an economic, simple, cheap, and repeatable outpatient procedure. It can be chosen as the first-line therapeutic modality in suitable patients with HCs.
背景/目的：经皮途径被认为是治疗包虫囊肿（HCs）最便捷的方法。本研究旨在分析用于治疗包虫囊肿的奥尔梅西技术的疗效。
这是一项回顾性队列研究。纳入自1991年以来就诊于安卡拉大学医学院胃肠病学系的HCs患者。分析世界卫生组织囊型棘球蚴病（WHO-CE）1型、2型、3A - 3B型活囊肿且至少接受过一次经皮治疗并至少随访6个月的患者。
自1991年以来，共有1035例患者的1556个囊性病变就诊于我科。479例患者的544个活HCs采用奥尔梅西技术进行治疗。女性的平均随访时间为59.29个月，男性为57.18个月。采用奥尔梅西技术治疗的所有囊肿的总体临床成功率为94.5%。治疗后，所有WHO-CE囊肿类型的囊肿大小均有统计学意义的下降（所有P <.001）。未检测到死亡率、脓肿和瘘管形成、硬化性胆管炎及药物毒性。在544个囊肿中，只有2例患者在治疗期间出现可逆性过敏反应（0.36%）。
对于WHO-CE 1型、2型和3B型包虫囊肿，可通过奥尔梅西技术经皮治疗，成功率较高。奥尔梅西技术是一种经济、简单、廉价且可重复的门诊手术。对于合适的HCs患者，可将其作为一线治疗方式。
